Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug Choice Particularly Important In Medicare Population – PhRMA Study

This article was originally published in The Pink Sheet Daily

Executive Summary

A PhRMA-sponsored study of ACE inhibitor, SSRI and insulin labels examined differences within the classes, including indication, route of elimination and interactions. Drug variations and characteristics of the elderly population make flexibility particularly important when designing formularies for the Medicare drug benefit, the study concludes.
Advertisement

Related Content

USP Draft Medicare Formulary Sets 146 Drug Categories And Classes
USP Draft Medicare Formulary Sets 146 Drug Categories And Classes
USP Medicare Formulary Classes Should Use Mechanism Of Action, PhRMA Says

Topics

Advertisement
UsernamePublicRestriction

Register

PS060387

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel